Skip to main content
logo
Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
36.99
+0.44 (1.20%)
At close: Jun 25, 2026, 4:00 PM EDT
36.59
-0.40 (-1.08%)
After-hours: Jun 25, 2026, 6:37 PM EDT

Rigel Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
684784298253260455
Market Cap Growth
75.26%163.27%17.51%-2.54%-42.80%-23.26%
Enterprise Value
583.43682.61280.53257.14243.45360.34
Last Close Price
36.9942.8316.8214.5015.0026.50
PE Ratio
1.952.2016.99---
Forward PE
9.9110.4917.39---
PS Ratio
2.282.661.662.172.163.05
PB Ratio
1.712.0090.60-8.85-19.1014.97
P/TBV Ratio
1.892.20---14.88
P/FCF Ratio
8.6310.379.48--86.60
P/OCF Ratio
8.6310.379.47--77.36
EV/Sales Ratio
1.952.321.562.202.022.41
EV/EBITDA Ratio
4.595.3410.62---
EV/EBIT Ratio
4.685.4411.60---
EV/FCF Ratio
7.369.028.92--68.62
Debt / Equity Ratio
0.040.0615.94-1.84-2.970.68
Debt / EBITDA Ratio
0.360.422.27---
Debt / FCF Ratio
0.580.711.91--5.82
Net Debt / Equity Ratio
-0.25-0.26-5.28-0.131.22-3.11
Net Debt / EBITDA Ratio
-0.79-0.79-0.66-0.190.318.33
Net Debt / FCF Ratio
-1.27-1.34-0.55-0.630.22-17.98
Asset Turnover
0.590.871.280.930.801.07
Inventory Turnover
1.712.243.240.970.220.26
Quick Ratio
2.202.081.881.641.512.21
Current Ratio
2.622.422.131.861.782.43
Return on Equity (ROE)
92.05%185.94%-137.92%118.75%-699.04%-55.63%
Return on Assets (ROA)
73.07%111.57%16.38%-16.29%-36.84%-9.31%
Return on Invested Capital (ROIC)
110.93%189.26%42.09%-48.45%-131.03%-32.41%
Return on Capital Employed (ROCE)
30.04%48.72%29.39%-30.81%-64.28%-14.42%
Earnings Yield
53.22%45.48%5.89%---
FCF Yield
11.58%9.65%10.55%--1.15%
Buyback Yield / Dilution
-7.67%-6.52%-1.64%-2.06%0.00%-1.03%
Total Shareholder Return
-7.67%-6.52%-1.64%-2.06%0.00%-1.03%
SEC Filings: 10-K · 10-Q